Evaluation of Microbial and Endocrinological Parameters in Dialysis Patients With Sepsis
NCT06963853 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2025-05-14
Summary
This prospective study aims to evaluate the diagnostic value and reliability of blood cultures obtained from different sources-central venous catheter (CVC), dialysis machine, and peripheral vein-in hemodialysis patients with suspected catheter-related bloodstream infections (CRBSIs). By comparing the timing and rates of bacterial growth from each site, the study seeks to identify the most accurate and timely method for diagnosing bloodstream infections in this patient population.
In addition, the study will assess the dynamics of parathyroid hormone (PTH) levels during acute infections. Specifically, it will investigate whether a significant drop in PTH levels-and the rate of recovery following infection-correlates with adverse outcomes such as infectious complications, cardiovascular morbidity, or 90-day mortality. These findings may offer valuable prognostic insights and support improved monitoring and treatment strategies for dialysis patients experiencing infection.
Conditions
- Sepsis
- Hemodialysis
Interventions
- DIAGNOSTIC_TEST
-
Blood cultures will be obtained from three sources: 1. The central venous catheter (CVC), 2. The dialysis machine circuit, and 3. A peripheral vein
PTH levels during sepsis and compare them to baseline pre-infection levels, with serial follow-up of PTH values post-recovery.
Sponsors & Collaborators
-
Western Galilee Hospital-Nahariya
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-08-16
- Primary Completion
- 2027-01-31
- Completion
- 2027-12-31
Countries
- Israel
Study Locations
More Related Trials
-
Study of Ceftazidime-Avibactam Blood Concentrations in Intensive Care Unit Patients With Renal Failure Requiring Continuous Dialysis
NCT03243864 ·Status: UNKNOWN
-
Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria
NCT00037050 ·Status: COMPLETED ·Phase: PHASE3
-
Perioperative Antibiotic Therapy to Prevent Cardiac Implantable Electronic Device Infections.
NCT02809131 ·Status: COMPLETED ·Phase: PHASE3
-
Reduction of Bacteriuria in Subjects Practicing Intermittent Catheterization
NCT01143116 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetic Assessment of Ceftazidime in Intermittent Hemodialysis Patients
NCT01507532 ·Status: WITHDRAWN ·Phase: PHASE4
-
Virulence of Staphylococcus Lugdunensis in Severe Infections
NCT02026895 ·Status: COMPLETED ·Phase: NA
-
BALANCE+ Vanguard Phase
NCT05893147 ·Status: COMPLETED ·Phase: NA
-
Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections
NCT00108433 ·Status: TERMINATED ·Phase: PHASE3
-
Effect of Vancomycin After Catheter Replacement
NCT04856878 ·Status: UNKNOWN ·Phase: PHASE4
-
Mupirocin 2% Ointment Vs Spray Antibiotics on Temporary Hemodialysis Catheter
NCT05874219 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Platform Trial for Gram Negative Bloodstream Infections
NCT06537609 ·Status: RECRUITING ·Phase: NA
-
Diagnostic Performance of Plasma Procalcitonin for the Detection of Blood Cultures Contaminations
NCT04573894 ·Status: COMPLETED
-
Pharmacokinetics of Daptomycin in Critically Ill Patients Receiving Continuous Venovenous Hemodialysis (CVVHD)
NCT00663403 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Dalbavancin Versus Vancomycin in the Treatment of Catheter-Related Bloodstream Infections
NCT00057369 ·Status: UNKNOWN ·Phase: PHASE2
-
Prevention of Catheter-Related Bloodstream Infection in Patients With Hemato-Oncological Disease
NCT00413738 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of MBI 226 for the Prevention of Central Venous Catheter-Related Bloodstream Infections
NCT00027248 ·Status: COMPLETED ·Phase: PHASE3
-
Molecular Characterization of Carbapenemase-Producing Enterobacterales
NCT07116356 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluation of an Antibiotic Regimen Pharmacokinetic Applicable to Enterococcus Faecalis Infective Endocarditis
NCT03681431 ·Status: COMPLETED ·Phase: PHASE2
-
A Combination Therapy With Ceftazidime and Fosfomycin Will be Compared to Ceftazidime Alone in Hospitalized Adult Patients With Suspected Severe Gram-negative Bacterial Infections
NCT07063095 ·Status: RECRUITING ·Phase: PHASE3
-
Cystatin-C C-guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project
NCT02945241 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of Performing a Rapid Antibiotic Susceptibility Test on Antibiotic Therapy Adaptation in Adult Patients with Enterobacterales Bacteremia
NCT06425367 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Pharmacokinetic / Pharmacodynamic Data and Interest Individualized Therapeutic Drug Monitoring Glycopeptides and β-lactam-aminoglycoside ICU
NCT02846298 ·Status: UNKNOWN
-
Port Protectors for Prevention of CLABSIs in Respiratory Semi-intensive Care Unit
NCT03486093 ·Status: COMPLETED ·Phase: NA
-
Safety and Tolerability of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections (0826-055)
NCT01014013 ·Status: COMPLETED ·Phase: PHASE3
-
FOUR-SIX TRIAL for the Treatment of Enterococcal Endocarditis
NCT05398289 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4